MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2016. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,088,667 | +50.9% | 153,227 | +43.2% | 0.01% | +57.1% |
| Q3 2022 | $3,373,000 | -13.5% | 106,998 | -16.5% | 0.01% | -12.5% |
| Q2 2022 | $3,900,000 | +437.2% | 128,215 | +358.5% | 0.01% | +700.0% |
| Q1 2022 | $726,000 | -69.3% | 27,962 | -77.9% | 0.00% | -92.3% |
| Q4 2020 | $2,363,000 | +56.4% | 126,430 | +42.1% | 0.01% | +30.0% |
| Q3 2020 | $1,511,000 | +7.5% | 88,947 | -46.9% | 0.01% | -28.6% |
| Q1 2020 | $1,406,000 | -70.8% | 167,361 | -66.0% | 0.01% | -57.6% |
| Q4 2019 | $4,807,000 | +30.8% | 492,034 | +27.1% | 0.03% | +13.8% |
| Q3 2019 | $3,675,000 | -1.1% | 387,199 | +23.8% | 0.03% | -6.5% |
| Q2 2019 | $3,717,000 | +30.1% | 312,886 | +92.7% | 0.03% | +138.5% |
| Q1 2019 | $2,858,000 | -31.2% | 162,330 | -32.2% | 0.01% | -69.0% |
| Q4 2018 | $4,156,000 | +1596.3% | 239,388 | +1801.9% | 0.04% | +2000.0% |
| Q2 2016 | $245,000 | -82.5% | 12,587 | -83.2% | 0.00% | -88.9% |
| Q2 2015 | $1,398,000 | – | 75,021 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |